Zoran Filipovic

7.4k total citations · 3 hit papers
17 papers, 5.3k citations indexed

About

Zoran Filipovic is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Zoran Filipovic has authored 17 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Cell Biology. Recurrent topics in Zoran Filipovic's work include Cancer-related Molecular Pathways (10 papers), Ubiquitin and proteasome pathways (6 papers) and Microtubule and mitosis dynamics (4 papers). Zoran Filipovic is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Ubiquitin and proteasome pathways (6 papers) and Microtubule and mitosis dynamics (4 papers). Zoran Filipovic collaborates with scholars based in United States, Switzerland and Germany. Zoran Filipovic's co-authors include Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves, Frank Podlaski, Emily A. Liu, Christine Lukacs, Nader Fotouhi, Norman Kong, Daisy Carvajal and Christian Klein and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Cancer Research.

In The Last Decade

Zoran Filipovic

16 papers receiving 5.2k citations

Hit Papers

3 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

2004 3.7k citations Lyubomir T. Vassilev, Binh Thanh Vu et al. Science profile →
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy

2006 553 citations Christian Tovar, James Rosinski et al. Proceedings of the National Academy of Sciences profile →
Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development

2013 447 citations Qingjie Ding, Zhuming Zhang et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zoran Filipovic United States	10	3.9k	3.2k	695	608	510	17	5.3k
Binh Thanh Vu Vietnam	17	4.2k 1.1×	3.4k 1.1×	733 1.1×	742 1.2×	567 1.1×	48	5.8k
Christine Lukacs United States	21	3.9k 1.0×	2.5k 0.8×	637 0.9×	625 1.0×	401 0.8×	35	5.3k
Emily A. Liu United States	5	2.9k 0.7×	2.3k 0.7×	489 0.7×	448 0.7×	359 0.7×	5	3.9k
U. Kammlott United States	7	3.1k 0.8×	2.3k 0.7×	520 0.7×	522 0.9×	361 0.7×	8	4.0k
Bradford Graves United States	26	5.2k 1.3×	3.6k 1.1×	778 1.1×	1.1k 1.9×	545 1.1×	45	7.3k
Norman Kong United States	7	2.9k 0.7×	2.2k 0.7×	489 0.7×	1.1k 1.8×	365 0.7×	11	4.4k
Kathryn Packman United States	28	2.6k 0.7×	2.2k 0.7×	484 0.7×	343 0.6×	219 0.4×	65	3.9k
Nancy E. Kohl United States	42	5.2k 1.3×	2.4k 0.8×	843 1.2×	757 1.2×	183 0.4×	97	8.0k
David Heimbrook United States	34	3.0k 0.8×	2.3k 0.7×	472 0.7×	369 0.6×	295 0.6×	69	4.6k
Tona M. Gilmer United States	30	4.0k 1.0×	3.8k 1.2×	850 1.2×	497 0.8×	262 0.5×	60	6.8k

Countries citing papers authored by Zoran Filipovic

Since Specialization

Citations

This map shows the geographic impact of Zoran Filipovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoran Filipovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoran Filipovic more than expected).

Fields of papers citing papers by Zoran Filipovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoran Filipovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoran Filipovic. The network helps show where Zoran Filipovic may publish in the future.

Co-authorship network of co-authors of Zoran Filipovic

This figure shows the co-authorship network connecting the top 25 collaborators of Zoran Filipovic. A scholar is included among the top collaborators of Zoran Filipovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoran Filipovic. Zoran Filipovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Filipovic, Zoran, et al.. (2024). Timely Surgical Resection Achieved Prolonged Remission in Patients With Malignant Mesothelioma of the Tunica Vaginalis Testis and Retroperitoneal Recurrence. Cureus. 16(4). e59052–e59052.

Filipovic, Zoran & Alexander F. Wagner. (2019). The Intangibles Song in Takeover Announcements: Good Tempo, Hollow Tune. SSRN Electronic Journal. 4 indexed citations

Filipovic, Zoran, et al.. (2017). Computational analysis of unmanned aerial vehicle (UAV). AIP conference proceedings. 1798. 20001–20001. 3 indexed citations

Huang, Zhihong, Zoran Filipovic, Raymond W. Colburn, et al.. (2016). AC105 Increases Extracellular Magnesium Delivery and Reduces Excitotoxic Glutamate Exposure within Injured Spinal Cords in Rats. Journal of Neurotrauma. 34(3). 685–694. 6 indexed citations

Higgins, Brian, Christian Tovar, Aruna Railkar, et al.. (2015). Abstract A156: Preclinical activity of MDM2 antagonist RO6839921, a pegylated prodrug for intravenous administration. Molecular Cancer Therapeutics. 14(12_Supplement_2). A156–A156. 4 indexed citations

Zhang, Zhuming, Qingjie Ding, Jinjun Liu, et al.. (2014). Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy. Bioorganic & Medicinal Chemistry. 22(15). 4001–4009. 42 indexed citations

Higgins, Brian, Kelli Glenn, Antje‐Christine Walz, et al.. (2014). Preclinical Optimization of MDM2 Antagonist Scheduling for Cancer Treatment by Using a Model-Based Approach. Clinical Cancer Research. 20(14). 3742–3752. 50 indexed citations

Ding, Qingjie, Zhuming Zhang, Jinjun Liu, et al.. (2013). Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development. Journal of Medicinal Chemistry. 56(14). 5979–5983. 447 indexed citations breakdown →

Tovar, Christian, Bradford Graves, Kathryn Packman, et al.. (2013). MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models. Cancer Research. 73(8). 2587–2597. 220 indexed citations

10.

Higgins, Brian, Christian Tovar, Kelli Glenn, et al.. (2013). Abstract B55: Antitumor activity of the MDM2 antagonist RG7388.. Molecular Cancer Therapeutics. 12(11_Supplement). B55–B55. 3 indexed citations

11.

Zhang, Zhuming, Xin‐Jie Chu, Jinjun Liu, et al.. (2013). Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development. ACS Medicinal Chemistry Letters. 5(2). 124–127. 68 indexed citations

12.

Tovar, Christian, Zoran Filipovic, Thelma Thompson, et al.. (2012). Abstract 4727: Antitumor activity of the MDM2 antagonist, RG7112. Cancer Research. 72(8_Supplement). 4727–4727. 1 indexed citations

13.

Tovar, Christian, James Rosinski, Zoran Filipovic, et al.. (2006). Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy. Proceedings of the National Academy of Sciences. 103(6). 1888–1893. 553 indexed citations breakdown →

14.

Vassilev, Lyubomir T., Binh Thanh Vu, Bradford Graves, et al.. (2004). In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2. Science. 303(5659). 844–848. 3722 indexed citations breakdown →

15.

Yang, Hong, Zoran Filipovic, David A. Brown, Samuel N. Breit, & Lyubomir T. Vassilev. (2003). Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation.. PubMed. 2(10). 1023–9. 141 indexed citations

16.

Filipovic, Zoran, et al.. (2002). Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock. Intensive Care Medicine. 28(8). 1164–1167. 12 indexed citations

17.

Kerr, Steven, et al.. (1999). Repeated Measurement of Intestinal Permeability as an Assessment of Colitis Severity in HLA-B27 Transgenic Rats. Journal of Pharmacology and Experimental Therapeutics. 291(2). 903–910. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact